Market Rally Lifts Tech Stocks: Which Best Rate Movers Dominated Monday's Trading Session

Monday’s Market Surge: A Reversal Worth Noting

After a turbulent week, equity markets staged a impressive comeback on Monday, November 24. The technology sector led the charge, with the Nasdaq Composite surging nearly 3%, while the S&P 500 climbed 1.55% and the Dow Jones Industrial Average gained 0.44%. This renewed bullish sentiment appeared almost ahead of the Thanksgiving holiday—investors decided not to wait before celebrating the market’s rebound.

The broad rally reflected easing concerns about the sustainability of artificial intelligence investments. Despite ongoing questions about whether the AI spending boom can sustain itself, fresh announcements from major tech players reignited buyer enthusiasm across the sector.

Driving Forces Behind the Rally

Two major catalysts fueled Monday’s advance. First, Alphabet and its Google division drew positive commentary over the weekend regarding their AI initiatives, which proved beneficial for semiconductor suppliers like Broadcom. Second, Amazon unveiled aggressive plans to deploy tens of billions of dollars into AI infrastructure—a development that significantly boosted chip manufacturers’ stock valuations.

The market’s enthusiasm suggests that while investors harbor long-term doubts about AI spending sustainability, they remain eager to bid up stocks whenever major new investment commitments materialize.

Top Performers: How Best Rate Movers Captured Gains

Broadcom (AVGO): Rising 11%

Broadcom, the semiconductor powerhouse, emerged as one of Monday’s best rate movers, climbing 11%. The company benefits as a critical chipmaker supplying Alphabet and supporting Amazon’s infrastructure expansion. With both tech giants making substantial AI infrastructure commitments, Broadcom’s position as a crucial intermediary in the AI supply chain continues to attract investor capital.

Oscar Health (OSCR): Surging 22%

Oscar Health, the health insurance provider, became Monday’s most dramatic gainer, advancing 22%. The rally stemmed from optimistic signals about a potential Washington compromise regarding Affordable Care Act premium subsidies. Following the recent government shutdown in October and early November, shareholders had feared subsidies might not be extended—a scenario that could damage the insurer’s economics. The Trump administration’s announcement suggesting a possible temporary extension of ACA subsidies injected hope into the stock, reversing months of decline from its October peak.

Notable Decliners: Where Best Rate Movers Stumbled

Novo Nordisk (NVO): Down 6%

Novo Nordisk stumbled 6% after announcing disappointing results from its clinical trial examining whether its GLP-1 semaglutide drug could slow Alzheimer’s disease progression. Despite the drugmaker’s attempt to frame the trial as exploratory, investors reacted negatively. Given how elusive effective Alzheimer’s treatments have proven to be, the failure represented another setback in an area where successful breakthroughs remain scarce. CEO Mike Doustdar acknowledged the trial had always been speculative, but market sentiment suggested investors had held higher hopes.

Abercrombie & Fitch (ANF): Declining 6%

Abercrombie & Fitch fell 6% as the retail chain approaches Tuesday’s quarterly earnings announcement. Investors braced for weak results in both the reported quarter and potentially for the full year. Mixed signals about holiday shopping create uncertainty across retail, with the National Retail Federation projecting higher spending while major retailers warn of consumer caution due to employment market concerns and persistent inflation. The stock has now lost more than 50% of its value in 2025, reflecting broader retail sector weakness.

Market Takeaway

Monday’s rally underscores how market momentum shifts when new AI spending commitments emerge, even as structural questions about the sector’s sustainability persist. The best rate movers—whether tech beneficiaries like Broadcom or benefit-of-doubt plays like Oscar Health—captured gains as investor sentiment swung decisively positive. However, Monday’s losers remind participants that not all sectors participate equally in rallies, with healthcare innovation disappointments and retail sector structural headwinds continuing to weigh on specific names.